Trials to test a vaccine to prevent the development of Type-1 diabetes may start as early as next year. The research is based on the idea that a group of viruses, known as enteroviruses, are thought to play a role in the development of Type-1 diabetes. The next round of trials will assess whether or not the vaccine is safe in 30 adult humans. The vaccine has so far been tested successfully in mice, with the first phase of human trials expected to begin in Finland in late 2018. "Additionally, the vaccine would protect from infections caused by enteroviruses such as the common cold, myocarditis, meningitis, and ear infections.
Diabetes Vaccine Entering Human Testing Could Also Prevent the Common Cold
After years of preliminary studies, researchers at the University of Tampere, in Finland, are finally ready to test their diabetes vaccine in clinical trials. With that information in hand, they set out to create a prototype vaccine. "The aim is to develop a vaccine that could prevent a significant number of type 1 diabetes cases. Enteroviruses are RNA-based viruses linked to many human ailments, including polio; the common cold; hand, foot and mouth disease; and several others. Additionally, the vaccine would protect from infections caused by enteroviruses such as the common cold, myocarditis, meningitis and ear infections.
collected by :Lucy William
No comments:
Post a Comment